Castanospermine, an oligosaccharide processing inhibitor, reduces membrane expression of adhesion molecules and prolongs heart allograft survival in rats

Transplant Immunology

Volumn 4, Issue 4, 1996, Pages 275-285

  Grochowicz, Pawel M ^a   Hibberd, Adrian D ^a   Smart, Y Cheng ^b   Bowen, Kerry M ^b   Clark, David A ^a   Cowden, William B ^b   Willenborg, David O ^b  

^a JOHN HUNTER HOSPITAL   (Australia)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CASTANOSPERMINE; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; FLOW CYTOMETRY; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOPEROXIDASE STAINING; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0030467955     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(96)80048-7     Document Type: Article

References (39)

1. 1 Myers BD, Sibley R, Newton L et al. The long term course of cyclosporine-associated chronic nephropathy. Kidney Int. 1988; 33; 590-600.
2. 2 Brayman KL, Stephanian E, Matas AJ, Schmidt W, Payne WD, Sutherland DER. Analysis of infectious complications occurring after solid organ transplantation. Arch Surg 1992; 127: 38-48.
3. 3 Sheil AGR. Cancer in organ transplant recipients: part of an induced immune deficiency syndrome. BMJ 1984; 288: 659-70.
4. 4 Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporin in cadaveric renal transplantation. N Engl J Med 1983; 309: 809-15.
5. 5 Berenbaum MC. Synergy, additivism and antagonism in immunosuppression. A critical review. Clin Exp Immunol 1977; 28: 1-18.
6. 6 Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51: 1141-51.
7. 7 Springer TA. Adhesion receptors of the immune system. Nature 1990; 346: 425-34.
8. 8 Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992; 13: 106-12.
9. 9 Naparstek Y, Cohen IR, Fuks Z, Vlodavsky I. Activated T lymphocytes produce a matrix degrading heparan sulphate endoglycosidase. Nature 1984; 310: 241-44.
10. 10 Savion N, Vlodavsky I, Fuks Z. Interaction of T lymphocytes and macrophages with cultured vascular endothelial cells: attachment, invasion and subsequent degradation of the subendothelial extracellular matrix. J Cell Physiol 1984; 118: 169-71.
11. 11 Saul R, Ghidoni JJ, Molyneux RJ, Elbein AD. Castanospermine inhibits α-glucosidase activities and alters glycogen distribution in animals. Proc Natl Acad Sci USA 1985; 82: 93-97.
12. 12 Sasak VW, Ordovas JM, Elbein AD, Berninger RW. Castanospermine inhibits glucosidase I and glycoprotein secretion in human hepatoma cells. Biochem J 1985; 232: 759-66.
13. 13 Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985; 54: 631-64.
14. 14 Grochowicz PM, Hibberd AD, Bowen KM, Clark DA, Cowden WB, Willenborg DO. Castanospermine, an α-glucosidase inhibitor, prolongs renal allograft survival in the rat. Transplant Proc 1990; 22: 2117-18.
15. 15 Grochowicz PM, Bowen KM, Hibberd AD, Cowdon WB, Willenborg DO. Castanospermine, an α-glucosidase inhibitor, prolongs survival of rodent primarily vascularized pancreaticoduodenal allografts. Transplant Proc 1992; 24: 2295-96.
16. 16 Grochowicz PM, Hibberd AD, Bowen KM, Clark DA, Cowden WB, Willenborg DO. Interference with carbohydrate processing by castanospermine prolongs organ allograft survival. Transplant Proc 1993; 25: 743-44.
17. 17 Bartlett MRE, Warren HS, Cowden WB, Parish CR. Effects of the anti-inflammatory compounds castanospermine, mannose-6-phosphate and fucoidan on allograft rejection and elicited peritoneal exudates. Immunol Cell Biol 1994; 72: 367-74.
18. 18 Willenborg DO, Parish CR, Cowden WB. Inhibition of experimental allergic encephalomyelitis by the α-glucosidase inhibitor castanospermine. J Neurol Sci 1989; 90: 77-85.
19. 19 Willenborg DO, Parish CR, Cowden WB. Inhibition of adjuvant arthritis in the rat by phosphosugars and the α-glucosidase inhibitor castanospermine. Immunol Cell Biol 1992; 70: 369-77.
20. 20 Ono K, Lindsey ES. Improved technique of heart transplantation in rats. J Thor Cardiovasc Surg 1969; 57: 225-27.
21. 21 Heslop BF. Histocompatibility antigens in the rat: AS2 strain in relation to the AS, BS and HS strains. Aust J Exp Biol Med Sci 1968; 46: 479-91.
22. 22 Hohenschutz LD, Bell EA, Jewess PJ et al. Castanospermine, a 1,6,7,8-tetrahydroxy-octahydroindolizine alkaloid, from seeds of Castanospermum australe. Phytochemistry 1981; 20: 811-14.
23. 23 Mason DW, Morris PJ. Inhibition of the accumulation, in rat kidney allografts of specific - but not non-specific - cytotoxic cells by cyclosporine. Transplantation 1984; 37: 46-50.
24. 24 Tarone RE. Tests for trend in life table analysis. Biometrika 1975; 62: 679-84.
25. 25 Grochowicz PM, Smart YC, Bowen KM et al. Castanospermine modifies expression of adhesion molecules in allograft recipients. Transplant Proc 1993; 25: 2900-901.
26. 26 Pawelec G. Suppressor cells in transplantation immunology: do recent advances in T cell immunobiology and cytokine networking contribute to the solution of an old conundrum. Transplant Immunol 1993; 1: 172-81.
27. 27 Wall KA, Pierce JD, Elbein AD. Inhibitors of glycoprotein processing alter T cell proliferative responses to antigen and to interleukin 2. Proc Natl Acad Sci USA 1988; 85: 5644-48.
28. 28 Talento A, Nguyen M, Blake T et al. A single administration of LFA-1 antibody confers prolonged allograft survival. Transplantation 1993; 55: 418-22.
29. 29 Isobe M, Yagita H, Okumura K, Ihara A. Specific acceptance of cardiac allograft after treatment with antibodies to ICAM-1 and LFA-1. Science 1992; 255: 1125-27.
30. 30 Komori A, Nagata M, Ochiai T et al. Role of ICAM-1 and LFA-1 in cardiac allograft rejection in the rat. Transplant Proc 1993; 25: 831-32.
31. 31 Isobe M, Ihara A. Tolerance induction against cardiac allografts by anti-ICAM-1 and anti-LFA-1 treatment: T cells respond to in vitro allostimulation. Transplant Proc 1993; 25: 1079-80.
32. 32 Cosimi AB, Conti D, Delmonico FL et al. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in non human primates with renal allografts. J Immunol 1990; 144: 4604-12.
33. 33 Haug CE, Colvin RB, Delmonico FL et al. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation 1993; 55: 766-73.
34. 34 Wacholtz MC, Patel SS, Lipsky PE. Leukocyte function - associated antigen-I is an activation molecule for human T cells. J Exp Med 1989; 170: 431-48.
35. 35 Harding FA, McArthur JG, Gross JA, Raulet DH, Alison JP. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy to T cell clones. Nature 1992; 356: 607-609.
36. 36 Renkonen R, Ustinov J. Carbohydrate synthesis inhibitors decrease interleukin 1 stimulated lymphocyte binding to endothelial cells. Eur J Immunol 1991; 21: 777-81.
37. 37 Moore SEH, Spiro RG. Inhibition of glucose trimming by castanospermine results in rapid degradation of unassembled major histocompatibility complex class I molecules. J Biol Chem 1993; 268: 3809-12.
38. 38 Arakaki RF, Hedo JA, Collier E, Gordon P. Effects of castanospermine and 1-deoxynojirimycin on insulin receptor biogenesis. J Biol Chem 1987; 262: 11886-92.
39. 39 Edwards EH, Sraque EA, Kelley JL, Kerbacher JJ, Schwartz JJ, Elbein AD. Castanospermine inhibits the function of the low density lipoprotein receptor. Biochemistry 1989; 28: 7679-87.